https://www.selleckchem.com/products/4u8c.html
To assess baseline clinical and urodynamic profiles of a contemporary cohort of men undergoing radical prostatectomy as part of the ROSE study. Men with localised prostate cancer undergoing radical prostatectomy were prospectively recruited to undergo clinical assessment and urodynamic testing prior to surgery as part of a clinical trial. 85 men with median age 64.5 years and median PSA 6.3 ng/ml were prospectively recruited. Of patients with complete baseline data, 36(50.7%), 28(39.4%) and 7(9.9%) had mild (IPSS 8), moderate (IPSS 8-1
Like
Comment
Share
